293 related articles for article (PubMed ID: 36173308)
1. The Intratumoral Bacterial Metataxonomic Signature of Hepatocellular Carcinoma.
Huang JH; Wang J; Chai XQ; Li ZC; Jiang YH; Li J; Liu X; Fan J; Cai JB; Liu F
Microbiol Spectr; 2022 Oct; 10(5):e0098322. PubMed ID: 36173308
[TBL] [Abstract][Full Text] [Related]
2. A distinct microbiota signature precedes the clinical diagnosis of hepatocellular carcinoma.
Yang J; He Q; Lu F; Chen K; Ni Z; Wang H; Zhou C; Zhang Y; Chen B; Bo Z; Li J; Yu H; Wang Y; Chen G
Gut Microbes; 2023; 15(1):2201159. PubMed ID: 37089022
[TBL] [Abstract][Full Text] [Related]
3. Gut microbiota dysbiosis with hepatitis B virus liver disease and association with immune response.
Yan F; Zhang Q; Shi K; Zhang Y; Zhu B; Bi Y; Wang X
Front Cell Infect Microbiol; 2023; 13():1152987. PubMed ID: 37201112
[TBL] [Abstract][Full Text] [Related]
4. Distinct alterations of gut microbiota between viral- and non-viral-related hepatocellular carcinoma.
Jinato T; Anuntakarun S; Satthawiwat N; Chuaypen N; Tangkijvanich P
Appl Microbiol Biotechnol; 2024 Dec; 108(1):34. PubMed ID: 38183473
[TBL] [Abstract][Full Text] [Related]
5. Integrated analysis of microbiome and host transcriptome reveals correlations between gut microbiota and clinical outcomes in HBV-related hepatocellular carcinoma.
Huang H; Ren Z; Gao X; Hu X; Zhou Y; Jiang J; Lu H; Yin S; Ji J; Zhou L; Zheng S
Genome Med; 2020 Nov; 12(1):102. PubMed ID: 33225985
[TBL] [Abstract][Full Text] [Related]
6. The interaction between intratumoral bacteria and metabolic distortion in hepatocellular carcinoma.
Xue C; Gu X; Shi Q; Ma X; Jia J; Su Y; Bao Z; Lu J; Li L
J Transl Med; 2024 Mar; 22(1):237. PubMed ID: 38439045
[TBL] [Abstract][Full Text] [Related]
7. Urinary microbiome-based metagenomic signature for the noninvasive diagnosis of hepatocellular carcinoma.
Cho EJ; Kim B; Yu SJ; Hong SK; Choi Y; Yi NJ; Lee KW; Suh KS; Yoon JH; Park T
Br J Cancer; 2024 Apr; 130(6):970-975. PubMed ID: 38278977
[TBL] [Abstract][Full Text] [Related]
8. The diagnostic potential of gut microbiome for early hepatitis B virus-related hepatocellular carcinoma.
Tang Y; Zhou H; Xiang Y; Cui F
Eur J Gastroenterol Hepatol; 2021 Dec; 33(1S Suppl 1):e167-e175. PubMed ID: 33208683
[TBL] [Abstract][Full Text] [Related]
9. Intestinal microecology in mice bearing diethylnitrosamine-induced primary hepatocellular carcinoma.
Zhou W; Zheng Y; Shang J; Wang H; Wang Y; Lu H; Wang X; Sui M
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2022 Aug; 51(4):438-453. PubMed ID: 37202098
[TBL] [Abstract][Full Text] [Related]
10. Gut microbial signatures of patients with primary hepatocellular carcinoma and their healthy first-degree relatives.
Feng J; Wu Y; Dai P; Wang D; Liu L; Chai B
J Appl Microbiol; 2023 Oct; 134(10):. PubMed ID: 37777841
[TBL] [Abstract][Full Text] [Related]
11. Characterization of Gut Microbiota and Exploration of Potential Predictive Model for Hepatocellular Carcinoma Microvascular Invasion.
Zhang N; Wang Z; Lv J; Zhang S; Liu Y; Liu T; Li W; Gong L; Zhang X; El-Omar EM; Lu W
Front Med (Lausanne); 2022; 9():836369. PubMed ID: 35372388
[TBL] [Abstract][Full Text] [Related]
12. Characterization of disease-associated microbiota in hepatocellular carcinoma.
Sun P; Li Z; Zhang B
J Cancer Res Ther; 2023 Aug; 19(4):881-891. PubMed ID: 37675712
[TBL] [Abstract][Full Text] [Related]
13. [Analysis of the dynamic changes in gut microbiota in patients with extremely severe burns by 16S ribosomal RNA high-throughput sequencing technology].
Pan YY; Fan YF; Li JL; Cui SY; Huang N; Jin GY; Chen C; Zhang C
Zhonghua Shao Shang Za Zhi; 2020 Dec; 36(12):1159-1166. PubMed ID: 33379852
[No Abstract] [Full Text] [Related]
14.
Chen T; Ding R; Chen X; Lu Y; Shi J; Lü Y; Tang B; Zhang W; Ye C; Yuan M; Yang Z
Bioengineered; 2021 Dec; 12(1):8233-8246. PubMed ID: 34592890
[TBL] [Abstract][Full Text] [Related]
15. Metagenomic identification of gut microbiota distribution on the colonic mucosal biopsy samples in patients with non-alcoholic fatty liver disease.
Delik A; Dinçer S; Ülger Y; Akkız H; Karaoğullarından Ü
Gene; 2022 Jul; 833():146587. PubMed ID: 35598686
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis B virus-related hepatocellular carcinoma exhibits distinct intratumoral microbiota and immune microenvironment signatures.
Liu Y; Kim ES; Guo H
J Med Virol; 2024 Feb; 96(2):e29485. PubMed ID: 38377167
[TBL] [Abstract][Full Text] [Related]
17. Gut microbiome alteration as a diagnostic tool and associated with inflammatory response marker in primary liver cancer.
Deng T; Li J; He B; Chen B; Liu F; Chen Z; Zheng J; Shi Z; Zhang T; Deng L; Yu H; Yang J; Wu L; Shan Y; Yu Z; Chen X; Wang Y; Chen G
Hepatol Int; 2022 Feb; 16(1):99-111. PubMed ID: 35064546
[TBL] [Abstract][Full Text] [Related]
18. Intratumoral Microbiota Changes with Tumor Stage and Influences the Immune Signature of Oral Squamous Cell Carcinoma.
Pratap Singh R; Kumari N; Gupta S; Jaiswal R; Mehrotra D; Singh S; Mukherjee S; Kumar R
Microbiol Spectr; 2023 Aug; 11(4):e0459622. PubMed ID: 37409975
[TBL] [Abstract][Full Text] [Related]
19. Hepatic stellate cell activation and senescence induced by intrahepatic microbiota disturbances drive progression of liver cirrhosis toward hepatocellular carcinoma.
Liu B; Zhou Z; Jin Y; Lu J; Feng D; Peng R; Sun H; Mu X; Li C; Chen Y
J Immunother Cancer; 2022 Jan; 10(1):. PubMed ID: 34996812
[TBL] [Abstract][Full Text] [Related]
20. In Vitro Lactic Acid Bacteria Anti-Hepatitis B Virus (HBV) Effect and Modulation of the Intestinal Microbiota in Fecal Cultures from HBV-Associated Hepatocellular Carcinoma Patients.
Yang J; Gao H; Zhang T; Fan Y; Wu Y; Zhao X; Li Y; Wu L; Zhao H; Yang L; Zhong H; Li L; Xie X; Wu Q
Nutrients; 2024 Feb; 16(5):. PubMed ID: 38474727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
